Pulmonx Corp Files 8-K on Operations
Ticker: LUNG · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-condition, operations-update
TL;DR
Pulmonx filed an 8-K on 7/30/25 for operational/financial updates.
AI Summary
Pulmonx Corporation filed an 8-K on July 30, 2025, to report on its results of operations and financial condition. The filing does not contain specific financial figures or operational details in the provided text, but it serves as a notification of these updates.
Why It Matters
This filing indicates Pulmonx is providing an update on its financial and operational status to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard procedural update and does not contain negative or positive financial disclosures in the provided text.
Key Players & Entities
- Pulmonx Corporation (company) — Registrant
- July 30, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 700 Chesapeake Drive (address) — Principal Executive Offices
- Redwood City, CA (location) — Principal Executive Offices City and State
FAQ
What is the primary purpose of this Form 8-K filing for Pulmonx Corporation?
The primary purpose of this Form 8-K filing is to report on Pulmonx Corporation's results of operations and financial condition.
On what date was this Form 8-K filed?
This Form 8-K was filed on July 30, 2025.
In which state is Pulmonx Corporation incorporated?
Pulmonx Corporation is incorporated in Delaware.
What is the address of Pulmonx Corporation's principal executive offices?
The address of Pulmonx Corporation's principal executive offices is 700 Chesapeake Drive, Redwood City, CA 94063.
Does the provided text of the 8-K filing contain specific financial figures?
No, the provided text of the 8-K filing does not contain specific financial figures or detailed operational results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Pulmonx Corp (LUNG).